Back
ProShares Ultra Nasdaq Biotechnology Vs. ProShares Ultra Real Estate Industry Stock Comparison
Sell
47
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
59.85
Seasonality Move:
16.48%
Buy
79
URE
ProShares Ultra Real Estate
Last Price:
77.15
Seasonality Move:
4.21%
Sell
47
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $59.65. The Score for BIB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
79
ProShares Ultra Real Estate (URE)
is a Buy
Is ProShares Ultra Real Estate a Buy, Sell or Hold?
- The current ProShares Ultra Real Estate [URE] share price is $77.01. The Score for URE is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- URE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $59.65
The current trend is relatively stagnant and BIB is experiencing buying pressure, which is a positive indicator for future bullish movement.
URE Stock Price Chart
What is ProShares Ultra Real Estate's stock price today?
-
The ProShares Ultra Real Estate share price today is $77.01
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and URE is experiencing slight selling pressure.
BIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.54 | Sell |
| Relative Strength Index (14 RSI): | 49.36 | Sell |
| Chaikin Money Flow: | 5357 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.39 - 64.31) | Sell |
| Bollinger Bands (100): | (60.2 - 67) | Sell |
URE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.62 | Buy |
| Relative Strength Index (14 RSI): | 63.6 | Buy |
| Chaikin Money Flow: | -3846 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (69.94 - 74.26) | Buy |
| Bollinger Bands (100): | (66.03 - 75.33) | Buy |
BIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.22 | Buy |
| 20-day SMA: | 59.86 | Sell |
| 50-day SMA: | 61.92 | Sell |
| 200-day SMA: | 59.96 | Sell |
| 8-day EMA: | 57.88 | Buy |
| 20-day EMA: | 59.17 | Buy |
| 50-day EMA: | 61.18 | Sell |
| 200-day EMA: | 60.1 | Sell |
URE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 73.36 | Buy |
| 20-day SMA: | 71.67 | Buy |
| 50-day SMA: | 73.17 | Buy |
| 200-day SMA: | 63.56 | Buy |
| 8-day EMA: | 74.01 | Buy |
| 20-day EMA: | 72.79 | Buy |
| 50-day EMA: | 72.22 | Buy |
| 200-day EMA: | 65.88 | Buy |
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Real Estate Earnings Growth & URE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProShares Ultra Real Estate Technical Analysis
| Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||